HuGE Literature Finder
|
||
Records 1-100
|
Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancer.
Journal of ovarian research 2019 May 12 (1): 40. Kim Se Ik, Lee Maria, Kim Hee Seung, Chung Hyun Hoon, Kim Jae-Weon, Park Noh Hyun, Song Yong-Sa |
|
Is BRCA mutational status a predictor of platinum-based chemotherapy related hematologic toxicity in high-grade serous ovarian cancer patients?
Gynecologic oncology 2019 May . Tomao Federica, Musacchio Lucia, Di Mauro Federica, Boccia Serena Maria, Di Donato Violante, Giancotti Antonella, Perniola Giorgia, Palaia Innocenza, Muzii Ludovico, Benedetti Panici Pierlui |
|
Large-scale meta-analysis of mutations identified in panels of breast/ovarian cancer-related genes - Providing evidence of cancer predisposition genes.
Gynecologic oncology 2019 Feb . Suszynska Malwina, Klonowska Katarzyna, Jasinska Anna J, Kozlowski Pio |
|
Germline mutations in cancer susceptibility genes in high grade serous ovarian cancer in Serbia.
Journal of human genetics 2019 Jan . Krivokuca Ana, Boljevic Ivana, Jovandic Stevo, Magic Zvonko, Mandic Aljosa, Tomasevic Zorica, Brankovic-Magic Mirja |
|
Prevalence and characterization of ATM germline mutations in Chinese BRCA1/2-negative breast cancer patients.
Breast cancer research and treatment 2019 Jan . Yang Ziguo, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Zhang Juan, Xie Yunt |
|
Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil.
BMC cancer 2019 Jan 19 (1): 4. Cotrim Deborah Porto, Ribeiro Adriana Regina Gonçalves, Paixão Daniele, de Queiroz Soares Diogo Cordeiro, Jbili Rima, Pandolfi Natasha Carvalho, Cezana Camila, de Cássia Mauro Carine, Mantoan Henrique, Bovolim Graziele, de Brot Louise, Torrezan Giovana Tardin, Carraro Dirce Maria, Baiocchi Glauco, da Cruz Formiga Maria Nirvana, da Costa Alexandre A B |
|
Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort.
International journal of cancer 2018 Sep . Li Jingmei, Wen Wei Xiong, Eklund Martin, Kvist Anders, Eriksson Mikael, Christensen Helene Nordahl, Torstensson Astrid, Bajalica-Lagercrantz Svetlana, Dunning Alison M, Decker Brennan, Allen Jamie, Luccarini Craig, Pooley Karen, Simard Jacques, Dorling Leila, Easton Douglas F, Teo Soo-Hwang, Hall Per, Borg Åke, Grönberg Henrik, Czene Kami |
|
BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls.
Gynecologic oncology 2018 Aug . Li Ang, Xie Rong, Zhi Qihuan, Deng Yixiao, Wu Yangming, Li Weiwei, Yang Lu, Jiao Zinan, Luo Jiaqi, Zi Yi, Sun Gang, Zhang Jiajia, Shi Yujian, Liu Ji |
|
BRCA1 and BRCA2 mutations and clinical interpretation in 398 ovarian cancer patients: comparison with breast cancer variants in a similar population.
Human genomics 2018 Aug 12 (1): 39. Cardoso Florencia C, Goncalves Susana, Mele Pablo G, Liria Natalia C, Sganga Leonardo, Diaz Perez Ignacio, Podesta Ernesto J, Solano Angela |
|
Contribution of RAD51D germline mutations in breast and ovarian cancer in Greece.
Journal of human genetics 2018 Aug . Konstanta Irene, Fostira Florentia, Apostolou Paraskevi, Stratikos Efstratios, Kalfakakou Despoina, Pampanos Andreas, Kollia Panagoula, Papadimitriou Christos, Konstantopoulou Irene, Yannoukakos Drakoul |
|
Biomarker Assessment of HR Deficiency, Tumor
Molecular cancer research : MCR 2018 Jul 16 (7): 1103-1111. Stronach Euan A, Paul James, Timms Kirsten M, Hughes Elisha, Brown Krystal, Neff Christopher, Perry Michael, Gutin Alexander, El-Bahrawy Mona, Steel Jennifer H, Liu Xinxue, Lewsley Liz-Anne, Siddiqui Nadeem, Gabra Hani, Lanchbury Jerry S, Brown Robe |
|
Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2018 Jul 47 (5): 2088-2096. Shi Tingyan, Wang Pan, Tang Wenbin, Jiang Rong, Yin Sheng, Shi Di, Wang Qing, Wei Qingyi, Zang Rong |
|
Validation and Implementation of BRCA1/2 Variant Screening in Ovarian Tumor Tissue.
The Journal of molecular diagnostics : JMD 2018 Jun . de Jonge Marthe M, Ruano Dina, van Eijk Ronald, van der Stoep Nienke, Nielsen Maartje, Wijnen Juul T, Ter Haar Natalja T, Baalbergen Astrid, Bos Monique E M M, Kagie Marjolein J, Vreeswijk Maaike P G, Gaarenstroom Katja N, Kroep Judith R, Smit Vincent T H B M, Bosse Tjalling, van Wezel Tom, van Asperen Christi |
|
BRCA1 and BRCA2 Germline Mutation Screening in Western Algeria using High Resolution Melting Analysis (HRM).
The Gulf journal of oncology 2018 May 1 (27): 31-37. Boulenouar Amina Chami Sidi, Coulet Florence, Bendiab Farida Mesli Taleb, Boudinar Fatima Zohra, Senhadji Rach |
|
Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers.
JAMA oncology 2018 Apr . Kotsopoulos Joanne, Gronwald Jacek, Karlan Beth Y, Huzarski Tomasz, Tung Nadine, Moller Pal, Armel Susan, Lynch Henry T, Senter Leigha, Eisen Andrea, Singer Christian F, Foulkes William D, Jacobson Michelle R, Sun Ping, Lubinski Jan, Narod Steven A, |
|
Risks of breast or ovarian cancer in BRCA1 or BRCA2 predictive test negatives: findings from the EMBRACE study.
Genetics in medicine : official journal of the American College of Medical Genetics 2018 Mar . Girardi Fabio, Barnes Daniel R, Barrowdale Daniel, Frost Debra, Brady Angela F, Miller Claire, Henderson Alex, Donaldson Alan, Murray Alex, Brewer Carole, Pottinger Caroline, Evans D Gareth, Eccles Diana, , Lalloo Fiona, Gregory Helen, Cook Jackie, Eason Jacqueline, Adlard Julian, Barwell Julian, Ong Kai Ren, Walker Lisa, Izatt Louise, Side Lucy E, Kennedy M John, Tischkowitz Marc, Rogers Mark T, Porteous Mary E, Morrison Patrick J, Eeles Ros, Davidson Rosemarie, Snape Katie, Easton Douglas F, Antoniou Antonis |
|
Combined annotation-dependent depletion score for BRCA1/2 variants in patients with breast and/or ovarian cancer.
Cancer science 2018 Feb 109 (2): 453-461. Nakagomi Hiroshi, Mochizuki Hitoshi, Inoue Masayuki, Hirotsu Yosuke, Amemiya Kenji, Sakamoto Ikuko, Nakagomi Satoko, Kubota Takeo, Omata Mas |
|
Difference in Risk of Breast and Ovarian Cancer According to Putative Functional Domain Regions in Korean BRCA1/2 Mutation Carriers.
Clinical breast cancer 2018 Feb . Park Ji Soo, Lee Seung-Tae, Han Jung Woo, Kim Tae Il, Nam Eun Ji, Park Hyung Se |
|
Routine germline BRCA1 and BRCA2 testing in ovarian carcinoma patients: analysis of the Scottish real life experience.
BJOG : an international journal of obstetrics and gynaecology 2018 Feb . Rust Kelly, Spiliopoulou Pavlina, Tang Chee Yuan, Bell Christine, Stirling Diane, Phang Tze Hui Fifi, Davidson Rosemarie, Mackean Melanie, Nussey Fiona, Glasspool Ros, Reed Nick, Sadozye Azmat, Porteous Mary, McGoldrick Trevor, Ferguson Michelle, Miedzybrodzka Zofia, McNeish Iain A, Gourley Charl |
|
Association of BRCA1/2 mutations with ovarian cancer prognosis: An updated meta-analysis.
Medicine 2018 Jan 97 (2): e9380. Huang Yong-W |
|
High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.
Breast cancer research and treatment 2018 Jan . Alhuqail Al-Joharah, Alzahrani Areej, Almubarak Hannah, Al-Qadheeb Sarah, Alghofaili Lamyaa, Almoghrabi Nisreen, Alhussaini Hamed, Park Ben Ho, Colak Dilek, Karakas Bed |
|
Identification and analysis of CHEK2 germline mutations in Chinese BRCA1/2-negative breast cancer patients.
Breast cancer research and treatment 2018 Jan . Fan Zhenhua, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Xu Ye, Xie Yunt |
|
Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?
PloS one 2018 13 (4): e0195497. Mitchell Rachel, Buckingham Lela, Cobleigh Melody, Rotmensch Jacob, Burgess Kelly, Usha Lyd |
|
Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancer.
Gynecologic oncology 2018 03 148 (3): 553-558. Kessous Roy, Octeau David, Klein Kathleen, Tonin Patricia N, Greenwood Celia M T, Pelmus Manuela, Laskov Ido, Kogan Liron, Salvador Shannon, Lau Susie, Yasmeen Amber, Gotlieb Walter |
|
Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations.
BMC cancer 2018 01 18 (1): 16. Hollis Robert L, Meynert Alison M, Churchman Michael, Rye Tzyvia, Mackean Melanie, Nussey Fiona, Arends Mark J, Sims Andrew H, Semple Colin A, Herrington C Simon, Gourley Charl |
|
Gene-panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplication.
Clinical genetics 2018 03 93 (3): 595-602. Pelttari L M, Shimelis H, Toiminen H, Kvist A, Törngren T, Borg Å, Blomqvist C, Bützow R, Couch F, Aittomäki K, Nevanlinna |
|
Genomic landscape of ovarian clear cell carcinoma via whole exome sequencing.
Gynecologic oncology 2018 02 148 (2): 375-382. Kim Se Ik, Lee Ji Won, Lee Maria, Kim Hee Seung, Chung Hyun Hoon, Kim Jae-Weon, Park Noh Hyun, Song Yong-Sang, Seo Jeong-S |
|
BRCA Mutation Status Is Not Associated With Increased Hematologic Toxicity Among Patients Undergoing Platinum-Based Chemotherapy for Ovarian Cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2017 Nov . Kotsopoulos Joanne, Willows Karla, Trat Sandra, Kim Raymond H, Volenik Alexandra, Sun Ping, Narod Steven A, Boyd Jeffrey, May Taym |
|
BRCA1/2 missense mutations and the value of in-silico analyses.
European journal of medical genetics 2017 Nov 60 (11): 572-577. Sadowski Carolin E, Kohlstedt Daniela, Meisel Cornelia, Keller Katja, Becker Kerstin, Mackenroth Luisa, Rump Andreas, Schröck Evelin, Wimberger Pauline, Kast Kar |
|
Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: an NRG Oncology/Gynecologic Oncology Group Study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Nov . Norquist Barbara M, Brady Mark F, Harrell Maria I, Walsh Tom, Lee Ming K, Gulsuner Suleyman, Bernards Sarah S, Casadei Silvia, Burger Robert A, Tewari Krishnansu S, Backes Floor J, Mannel Robert S, Glaser Gretchen, Bailey Cheryl, Rubin Stephen C, Soper John T, Lankes Heather A, Ramirez Nilsa C, King Mary-Claire, Birrer Michael J, Swisher Elizabeth |
|
CDH1 mutation screen in a BRCA1/2-negative familial breast-/ovarian cancer cohort.
Archives of gynecology and obstetrics 2017 Oct . Stuebs Frederik, Heidemann Simone, Caliebe Almuth, Mundhenke Christoph, Arnold Norbe |
|
Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations.
Biological research 2017 Oct 50 (1): 35. Jara Lilian, Morales Sebastian, de Mayo Tomas, Gonzalez-Hormazabal Patricio, Carrasco Valentina, Godoy Ra |
|
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
JAMA oncology 2017 Sep 3 (9): 1190-1196. Couch Fergus J, Shimelis Hermela, Hu Chunling, Hart Steven N, Polley Eric C, Na Jie, Hallberg Emily, Moore Raymond, Thomas Abigail, Lilyquist Jenna, Feng Bingjian, McFarland Rachel, Pesaran Tina, Huether Robert, LaDuca Holly, Chao Elizabeth C, Goldgar David E, Dolinsky Jill |
|
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers.
Nature communications 2017 Aug 8 (1): 319. Maxwell Kara N, Wubbenhorst Bradley, Wenz Brandon M, De Sloover Daniel, Pluta John, Emery Lyndsey, Barrett Amanda, Kraya Adam A, Anastopoulos Ioannis N, Yu Shun, Jiang Yuchao, Chen Hao, Zhang Nancy R, Hackman Nicole, D'Andrea Kurt, Daber Robert, Morrissette Jennifer J D, Mitra Nandita, Feldman Michael, Domchek Susan M, Nathanson Katherine |
|
Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women.
Journal of the National Cancer Institute 2017 Aug 109 (8): . Schmidt Marjanka K, van den Broek Alexandra J, Tollenaar Rob A E M, Smit Vincent T H B M, Westenend Pieter J, Brinkhuis Mariël, Oosterhuis Wolter J W, Wesseling Jelle, Janssen-Heijnen Maryska L, Jobsen Jan J, Jager Agnes, Voogd Adri C, van Leeuwen Flora E, van 't Veer Laura |
|
Elevated Serum Level of CA125 Is a Biomarker That Can Be Used to Alter Prognosis Determined by BRCA Mutation and Family History in Ovarian Cancer.
Genetic testing and molecular biomarkers 2017 Aug . Liu Weiling, Wang Zhizhong, Ma Jie, Hou Yangyang, Zhao Jiuzhou, Dong Bing, Tu Shichun, Wang Li, Guo Yongj |
|
Germline BRCA mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing.
Investigational new drugs 2017 Aug . Lee Kyoungmin, Yoo Changhoon, Kim Kyu-Pyo, Park Kyoung-Jin, Chang Heung-Moon, Kim Tae Won, Lee Jae-Lyun, Lee Woochang, Lee Sang Soo, Park Do Hyun, Song Tae Jun, Seo Dong Wan, Lee Sung Koo, Kim Myung-Hwan, Shin Sang Hyun, Hwang Dae Wook, Song Ki Byung, Lee Jae Hoon, Kim Song Cheol, Ryoo Baek-Ye |
|
Inherited predisposition to breast and ovarian cancer in non-Jewish populations in Israel.
Breast cancer research and treatment 2017 Aug . Zidan Jamal, Zhou Alicia Y, van den Akker Jeroen, Laitman Yael, Schayek Hagit, Schnaider Julia, Friedman Eit |
|
Recurrent large genomic rearrangements in BRCA1 and BRCA2 in an Irish case series.
Cancer genetics 2017 Aug 214-215 1-8. McVeigh Terri P, Cody Nuala, Carroll Cliona, Duff Marie, Farrell Michael, Bradley Lisa, Gallagher David, McDevitt Trudi, Green Andrew |
|
Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting.
Oncotarget 2017 Jul 8 (27): 43653-43661. Dougherty Brian A, Lai Zhongwu, Hodgson Darren R, Orr Maria C M, Hawryluk Matthew, Sun James, Yelensky Roman, Spencer Stuart K, Robertson Jane D, Ho Tony W, Fielding Anitra, Ledermann Jonathan A, Barrett J Ca |
|
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers.
Journal of the National Cancer Institute 2017 Jul 109 (7): . Kuchenbaecker Karoline B, McGuffog Lesley, Barrowdale Daniel, Lee Andrew, Soucy Penny, Dennis Joe, Domchek Susan M, Robson Mark, Spurdle Amanda B, Ramus Susan J, Mavaddat Nasim, Terry Mary Beth, Neuhausen Susan L, Schmutzler Rita Katharina, Simard Jacques, Pharoah Paul D P, Offit Kenneth, Couch Fergus J, Chenevix-Trench Georgia, Easton Douglas F, Antoniou Antonis |
|
Germline and somatic mutations in homologous recombination genes among Chinese ovarian cancer patients detected using next-generation sequencing.
Journal of gynecologic oncology 2017 Jul 28 (4): e39. Zhao Qianying, Yang Jiaxin, Li Lei, Cao Dongyan, Yu Mei, Shen Keng, |
|
Prevalence and Penetrance of BRCA1 and BRCA2 Germline Mutations in Colombian Breast Cancer Patients.
Scientific reports 2017 Jul 7 (1): 4713. Torres D, Bermejo J Lorenzo, Rashid M U, Briceño I, Gil F, Beltran A, Ariza V, Hamann |
|
High frequency of the recurrent c.1310_1313delAAGA BRCA2 mutation in the North-East of Morocco and implication for hereditary breast-ovarian cancer prevention and control.
BMC research notes 2017 Jun 10 (1): 188. Laarabi Fatima-Zahra, Ratbi Ilham, Elalaoui Siham Chafai, Mezzouar Loubna, Doubaj Yassamine, Bouguenouch Laila, Ouldim Karim, Benjaafar Noureddine, Sefiani Abdelaz |
|
Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates.
Journal of gynecologic oncology 2017 Jun . Helpman Limor, Zidan Omri, Friedman Eitan, Kalfon Sarit, Perri Tamar, Ben-Baruch Gilad, Korach Jac |
|
Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.
Familial cancer 2017 May . Gabaldó Barrios Xavier, Sarabia Meseguer Mª Desamparados, Marín Vera Miguel, Sánchez Bermúdez Ana Isabel, Macías Cerrolaza José Antonio, Sánchez Henarejos Pilar, Zafra Poves Marta, García Hernández Mª Rosario, Cuevas Tortosa Encarna, Aliaga Baño Ángeles, Castillo Guardiola Verónica, Martínez Hernández Pedro, Tovar Zapata Isabel, Martínez Barba Enrique, Ayala de la Peña Francisco, Alonso Romero José Luis, Noguera Velasco José Antonio, Ruiz Espejo Francis |
|
Impact of primary platinum-free interval and BRCA1/2 mutation status on treatment and survival in patients with recurrent ovarian cancer.
Gynecologic oncology 2017 Apr . Bookman Michael A, Tyczynski Jerzy E, Espirito Janet L, Wilson Thomas W, Fernandes Ancilla |
|
Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families.
Breast cancer (Tokyo, Japan) 2017 Mar 24 (2): 238-244. Riahi Aouatef, Ghourabi Mohamel El, Fourati Asma, Chaabouni-Bouhamed Habi |
|
Identification of large genomic rearrangement of BRCA1/2 in high risk patients in Korea.
BMC medical genetics 2017 Mar 18 (1): 38. Kim Do-Hoon, Chae Hyojin, Jo Irene, Yoo Jaeeun, Lee Hyeyoung, Jang Woori, Park Joonhong, Lee Gun Dong, Jeon Dong-Seok, Lee Keun Ho, Hur Soo Young, Chae Byung Joo, Song Byung Joo, Kim Myungshin, Kim Yongg |
|
PALB2 mutations in BRCA1/2-mutation negative breast and ovarian cancer patients from Poland.
BMC medical genomics 2017 Mar 10 (1): 14. Kluska Anna, Balabas Aneta, Piatkowska Magdalena, Czarny Katarzyna, Paczkowska Katarzyna, Nowakowska Dorota, Mikula Michal, Ostrowski Jer |
|
Prevalence of two BRCA1 mutations, 5382insC and 300T?>?G, in ovarian cancer patients from Ukraine.
Familial cancer 2017 Mar . Gorodetska I, Serga S, Lahuta T, Ostapchenko L, Demydov S, Khranovska N, Skachkova O, Inomistova M, Kolesnik O, Svintsitsky V, Tsip N, Peresunko A, Kmit' N, Manzhura O, Rossokha Z, Popova O, Salomakhina H, Kyriachenko S, Kozeretska |
|
Spectrum of genetic variants of BRCA1 and BRCA2 in a German single center study.
Archives of gynecology and obstetrics 2017 Mar . Meisel Cornelia, Sadowski Carolin Eva, Kohlstedt Daniela, Keller Katja, Stäritz Franziska, Grübling Nannette, Becker Kerstin, Mackenroth Luisa, Rump Andreas, Schröck Evelin, Arnold Norbert, Wimberger Pauline, Kast Kar |
|
High-risk epithelial ovarian cancer patients for hereditary ovarian cancer.
The journal of obstetrics and gynaecology research 2017 Feb . Chirasophon Seksit, Manchana Tarinee, Teerapakpinyo Chinacho |
|
Prognosis of patients with BRCA1-associated ovarian carcinomas depends on TP53 accumulation status in tumor cells.
Gynecologic oncology 2017 Feb 144 (2): 369-376. Rzepecka Iwona K, Szafron Lukasz M, Stys Agnieszka, Felisiak-Golabek Anna, Podgorska Agnieszka, Timorek Agnieszka, Sobiczewski Piotr, Pienkowska-Grela Barbara, El-Bahrawy Mona, Kupryjanczyk Jolan |
|
[Clinical significance and distribution of BRCA genes mutation in sporadic high grade serous ovarian cancer].
Zhonghua fu chan ke za zhi 2017 Jan 52 (1): 26-31. Liu W L, Wang Z Z, Zhao J Z, Hou Y Y, Wu X X, Li W, Dong B, Tong T T, Guo Y |
|
[Clinical-based study of ovarian cancer patients with and without BRCA1/2 genes mutation: clinical features and pedigree analysis].
Zhonghua fu chan ke za zhi 2017 Jan 52 (1): 20-25. Tao T, Yang J X, Shen K, Cao D |
|
BRCA1 and BRCA2 mutation predictions using the BRCAPRO and Myriad models in Korean ovarian cancer patients.
Gynecologic oncology 2017 04 145 (1): 137-141. Eoh Kyung Jin, Park Ji Soo, Park Hyung Seok, Lee Seung-Tae, Han Jeongwoo, Lee Jung-Yun, Kim Sang Wun, Kim Sunghoon, Kim Young Tae, Nam Eun |
|
BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
PloS one 2017 12 (11): e0187630. Alemar Bárbara, Gregório Cleandra, Herzog Josef, Matzenbacher Bittar Camila, Brinckmann Oliveira Netto Cristina, Artigalas Osvaldo, Schwartz Ida Vanessa D, Coffa Jordy, Alves Camey Suzi, Weitzel Jeffrey, Ashton-Prolla Patric |
|
Prevalence of BRCA1 and BRCA2 large genomic rearrangements in Tunisian high risk breast/ovarian cancer families: Implications for genetic testing.
Cancer genetics 2017 01 210 22-27. Riahi Aouatef, Chabouni-Bouhamed Habiba, Kharrat Mah |
|
Reanalysis of BRCA1/2 negative high risk ovarian cancer patients reveals novel germline risk loci and insights into missing heritability.
PloS one 2017 12 (6): e0178450. Stafford Jaime L, Dyson Gregory, Levin Nancy K, Chaudhry Sophia, Rosati Rita, Kalpage Hasini, Wernette Courtney, Petrucelli Nancie, Simon Michael S, Tainsky Michael |
|
The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: From BRCA1/2 to multi-gene panels.
PloS one 2017 12 (9): e0185615. Sung Pi-Lin, Wen Kuo-Chang, Chen Yi-Jen, Chao Ta-Chung, Tsai Yi-Fang, Tseng Ling-Ming, Qiu Jian-Tai Timothy, Chao Kuan-Chong, Wu Hua-Hsi, Chuang Chi-Mu, Wang Peng-Hui, Huang Chi-Ying |
|
Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil.
BMC cancer 2016 Dec 16 (1): 934. Maistro Simone, Teixeira Natalia, Encinas Giselly, Katayama Maria Lucia Hirata, Niewiadonski Vivian Dionisio Tavares, Cabral Larissa Garcia, Ribeiro Roberto Marques, Gaburo Junior Nelson, de Gouvêa Ana Carolina Ribeiro Chaves, Carraro Dirce Maria, Sabino Ester Cerdeira, Diz Maria Del Pilar Estevez, Chammas Roger, de Bock Geertruida Hendrika, Folgueira Maria Aparecida Azevedo Koi |
|
Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer.
Oncotarget 2016 Dec 7 (51): 85529-85541. Chao Angel, Chang Ting-Chang, Lapke Nina, Jung Shih-Ming, Chi Peter, Chen Chien-Hung, Yang Lan-Yan, Lin Cheng-Tao, Huang Huei-Jean, Chou Hung-Hsueh, Liou Jui-Der, Chen Shu-Jen, Wang Tzu-Hao, Lai Chyong-Hu |
|
RE: BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
Journal of the National Cancer Institute 2016 Dec 108 (12): . Arbustini Eloisa, Sgarella Adele, Ferrari Alberta, Grasso Donatella, Cassani Chiara, Lucioni Marco, Di Giulio Giuseppe, Grasso Mauriz |
|
Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.
British journal of cancer 2016 Oct . Zaaijer Leendert H, van Doorn Helena C, Mourits Marian J E, van Beurden Marc, de Hullu Joanne A, Adank Muriel A, van Lonkhuijzen Luc R C W, Vasen Hans F A, Slangen Brigitte F M, Gaarenstroom Katja N, Zweemer Ronald P, Vencken Peggy M L H, Seynaeve Caroline, Kriege Mie |
|
Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.
Oncotarget 2016 Oct . Fernandes Gabriela C, Michelli Rodrigo Ad, Galvão Henrique Cr, Paula André E, Pereira Rui, Andrade Carlos E, Felicio Paula S, Souza Cristiano P, Mendes Deise Rp, Volc Sahlua, Berardinelli Gustavo N, Grasel Rebeca S, Sabato Cristina S, Viana Danilo V, Mauad Edmundo C, Scapulatempo-Neto Cristovam, Arun Banu, Reis Rui M, Palmero Edenir |
|
Whole-exome sequencing of Finnish hereditary breast cancer families.
European journal of human genetics : EJHG 2016 Oct . Määttä Kirsi, Rantapero Tommi, Lindström Anna, Nykter Matti, Kankuri-Tammilehto Minna, Laasanen Satu-Leena, Schleutker Johan |
|
Frequency of germline PALB2 mutations among women with epithelial ovarian cancer.
Familial cancer 2016 Sep . Kotsopoulos Joanne, Sopik Victoria, Rosen Barry, Fan Isabel, McLaughlin John R, Risch Harvey, Sun Ping, Narod Steven A, Akbari Mohammad |
|
Gene panel sequencing in familial Breast/Ovarian Cancer patients identifies multiple novel mutations also in genes others than BRCA1/2.
International journal of cancer 2016 Sep . Kraus Cornelia, Hoyer Juliane, Vasileiou Georgia, Wunderle Marius, Lux Michael P, Fasching Peter A, Krumbiegel Mandy, Uebe Steffen, Reuter Miriam, Beckmann Matthias W, Reis And |
|
Molecular determination of the clonal relationships between multiple tumors in BRCA1/2-associated breast and/or ovarian cancer patients is clinically relevant.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Sep . Geurts-Giele Willemina R R, van Verschuer Victorien M T, van Deurzen Carolien H M, van Diest Paul J, Pedrosa Rute M S M, Collée J Margriet, Koppert Linetta B, Seynaeve Caroline, Dinjens Winand N |
|
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial.
The Lancet. Oncology 2016 Sep . Ledermann Jonathan A, Harter Philipp, Gourley Charlie, Friedlander Michael, Vergote Ignace, Rustin Gordon, Scott Clare, Meier Werner, Shapira-Frommer Ronnie, Safra Tamar, Matei Daniela, Fielding Anitra, Spencer Stuart, Rowe Philip, Lowe Elizabeth, Hodgson Darren, Sovak Mika A, Matulonis Ursu |
|
Prevalence of Hispanic BRCA1 and BRCA2 mutations among hereditary breast and ovarian cancer patients from Brazil reveals differences among Latin American populations.
Cancer genetics 2016 Sep 209 (9): 417-422. Alemar Bárbara, Herzog Josef, Brinckmann Oliveira Netto Cristina, Artigalás Osvaldo, Schwartz Ida Vanessa D, Matzenbacher Bittar Camila, Ashton-Prolla Patricia, Weitzel Jeffrey |
|
A BRCA1/2 mutational signature and survival in ovarian high grade serous carcinoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2016 Aug . Dong Fei, Davineni Phani K, Howitt Brooke E, Beck Andrew |
|
Neoplastic cellularity is associated with clinical and molecular features of high-grade serous ovarian carcinoma.
Gynecologic oncology 2016 Aug . Morse Christopher B, Norquist Barbara M, Harrell Maria I, Agnew Kathy J, Gray Heidi J, Urban Renata R, Garcia Rochelle L, Goff Barbara A, Swisher Elizabeth |
|
Next-Generation Sequencing of Tumors to Better Estimate the Clinical Significance of Non-BRCA Germline Deleterious Mutations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Aug . Sorscher Steven |
|
Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH.
Breast cancer research and treatment 2016 Aug . Hackmann Karl, Kuhlee Franziska, Betcheva-Krajcir Elitza, Kahlert Anne-Karin, Mackenroth Luisa, Klink Barbara, Di Donato Nataliya, Tzschach Andreas, Kast Karin, Wimberger Pauline, Schrock Evelin, Rump Andre |
|
Haplotype analysis reveals that the recurrent BRCA1 deletion of exons 23 and 24 is a Greek founder mutation.
Clinical genetics 2016 Jun . Apostolou Paraskevi, Pertesi Maroulio, Aleporou-Marinou Vassiliki, Dimitrakakis Constantine, Papadimitriou Christos, Razis Evangelia, Christodoulou Christos, Fountzilas George, Yannoukakos Drakoulis, Konstantopoulou Irene, Fostira Florent |
|
Detection of somatic BRCA1/2 mutations in ovarian cancer - next-generation sequencing analysis of 100 cases.
Cancer medicine 2016 May . Magdalena Koczkowska, Monika Zuk, Adam Gorczynski, Magdalena Ratajska, Marzena Lewandowska, Wojciech Biernat, Janusz Limon, Bartosz Was |
|
Ovarian cancer: Status of homologous recombination pathway as a predictor of drug response.
Critical reviews in oncology/hematology 2016 May 101 50-9. De Picciotto Nicolas, Cacheux Wulfran, Roth Arnaud, Chappuis Pierre O, Labidi-Galy S Intidh |
|
Commentary regarding Schayek et al., entitled "The rate of recurrent BRCA1, BRCA2, and TP53 mutations in the general population, and unselected ovarian cancer cases, in Belo Horizonte, Brazil".
Cancer genetics 2016 Apr . Sales Luiz Vianna Fernanda, Alemar Barbara, Achatz Maria Isabel, Camey Suzi Alves, Ashton-Prolla Patric |
|
Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer.
Oncotarget 2016 Apr . Zhou Meng, Sun Yanying, Sun Yifan, Xu Wanying, Zhang Zhaoyue, Zhao Hengqiang, Zhong Zhaohua, Sun J |
|
Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy.
Cancer 2016 Apr . Matulonis Ursula A, Harter Philipp, Gourley Charlie, Friedlander Michael, Vergote Ignace, Rustin Gordon, Scott Clare, Meier Werner, Shapira-Frommer Ronnie, Safra Tamar, Matei Daniela, Fielding Anitra, Spencer Stuart, Parry David, Grinsted Lynda, Ledermann Jonathan |
|
The rate of recurrent BRCA1, BRCA2, and TP53 mutations in the general population, and unselected ovarian cancer cases, in Belo Horizonte, Brazil.
Cancer genetics 2016 Apr . Schayek Hagit, De Marco Luiz, Starinsky-Elbaz Sigal, Rossette Mariana, Laitman Yael, Bastos-Rodrigues Luciana, Lopes da Silva Filho Agnaldo, Friedman Eit |
|
BRCA testing, treatment patterns and survival in platinum-sensitive recurrent ovarian cancer - an observational cohort study.
Journal of ovarian research 2016 Mar 9 18. Unni Sudhir K, Schauerhamer Marisa B, Deka Rishi, Tyczynski Jerzy E, Fernandes Ancilla W, Stevens Vanessa, Brixner Diana I, Stenehjem David |
|
BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study.
Gynecologic oncology 2016 Mar 140 (3): 443-9. Harter Philipp, Johnson Toby, Berton-Rigaud Dominique, Park Sang-Yoon, Friedlander Michael, Del Campo Josep M, Shimada Muneaki, Forget Frédéric, Mirza Mansoor R, Colombo Nicoletta, Zamagni Claudio, Chan John K, Imhof Martin, Herzog Thomas J, O'Donnell Dearbhaile, Heitz Florian, King Karen, Stinnett Sandy, Barrett Catherine, Jobanputra Minesh, Xu Chun-Fang, du Bois Andre |
|
Effectiveness of prophylactic surgeries in BRCA1 or BRCA2 mutation carriers: a meta-analysis and systematic review.
Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Mar . Li Xiao, You Ran, Wang Xinwei, Liu Congxin, Xu Zicheng, Zhou Jin, Yu Bin, Xu Ting, Cai Hongzhou, Zou Qi |
|
Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Mar . Tung Nadine, Lin Nancy U, Kidd John, Allen Brian A, Singh Nanda, Wenstrup Richard J, Hartman Anne-Renee, Winer Eric P, Garber Judy |
|
Molecular insights into the OGG1 gene, a cancer risk modifier in BRCA1 and BRCA2 mutations carriers.
Oncotarget 2016 Mar . Benitez-Buelga Carlos, Vaclová Tereza, Ferreira Sofia, Urioste Miguel, Inglada-Perez Lucia, Soberón Nora, Blasco Maria A, Osorio Ana, Benitez Javi |
|
BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population.
Familial cancer 2016 Feb . Nielsen Henriette Roed, Nilbert Mef, Petersen Janne, Ladelund Steen, Thomassen Mads, Pedersen Inge Søkilde, Hansen Thomas V O, Skytte Anne-Bine, Borg Åke, Therkildsen Christi |
|
Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis.
Familial cancer 2016 Feb . Sabatier Renaud, Lavit Elise, Moretta Jessica, Lambaudie Eric, Noguchi Tetsuro, Eisinger François, Cherau Elisabeth, Provansal Magali, Livon Doriane, Rabayrol Laetitia, Popovici Cornel, Charaffe-Jauffret Emmanuelle, Sobol Hagay, Viens Patri |
|
Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients.
Oncotarget 2016 Feb . Kim Yeong C, Zhao Linli, Zhang Hanwen, Huang Ye, Cui Jian, Xiao Fengxia, Downs Bradley, Wang San Mi |
|
Breast Cancer is Common in Women With Ovarian Malignant Mixed Mullerian Tumors.
American journal of clinical oncology 2016 Jan . Whynott Rachel M, Manahan Kelly J, Geisler John |
|
A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer.
BMC medical genomics 2016 9 (1): 19. Mucaki Eliseos J, Caminsky Natasha G, Perri Ami M, Lu Ruipeng, Laederach Alain, Halvorsen Matthew, Knoll Joan H M, Rogan Peter |
|
Analysis of Founder Mutations in Rare Tumors Associated With Hereditary Breast/Ovarian Cancer Reveals a Novel Association of BRCA2 Mutations with Ampulla of Vater Carcinomas.
PloS one 2016 11 (8): e0161438. Pinto Pedro, Peixoto Ana, Santos Catarina, Rocha Patrícia, Pinto Carla, Pinheiro Manuela, Leça Luís, Martins Ana Teresa, Ferreira Verónica, Bartosch Carla, Teixeira Manuel |
|
BRCA1 Gene Mutation Screening for the Hereditary Breast and/or Ovarian Cancer Syndrome in Breast Cancer Cases: a First High Resolution DNA Melting Analysis in Indonesia.
Asian Pacific journal of cancer prevention : APJCP 2016 17 (3): 1539-46. Mundhofir Farmaditya Ep, Wulandari Catharina Endah, Prajoko Yan Wisnu, Winarni Tri Ind |
|
BRCA1-2 diagnostic workflow from next-generation sequencing technologies to variant identification and final report.
Genes, chromosomes & cancer 2016 10 55 (10): 803-13. Pilato Brunella, Pinto Rosamaria, De Summa Simona, Petriella Daniela, Lacalamita Rosanna, Danza Katia, Paradiso Angelo, Tommasi Stefan |
|
Sensitivity of BRCA1/2 testing in high-risk breast/ovarian/male breast cancer families: little contribution of comprehensive RNA/NGS panel testing.
European journal of human genetics : EJHG 2016 11 24 (11): 1591-1597. Byers Helen, Wallis Yvonne, van Veen Elke M, Lalloo Fiona, Reay Kim, Smith Philip, Wallace Andrew J, Bowers Naomi, Newman William G, Evans D Gare |
|
Simultaneous detection of BRCA mutations and large genomic rearrangements in germline DNA and FFPE tumor samples.
Oncotarget 2016 09 7 (38): 61845-61859. Enyedi Márton Zsolt, Jaksa Gábor, Pintér Lajos, Sükösd Farkas, Gyuris Zoltán, Hajdu Adrienn, Határvölgyi Erika, Priskin Katalin, Haracska Laj |
|
Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy.
BMC medical genetics 2016 17 (1): 11. Cini Giulia, Mezzavilla Massimo, Della Puppa Lara, Cupelli Elisa, Fornasin Alessio, D'Elia Angela Valentina, Dolcetti Riccardo, Damante Giuseppe, Bertok Sara, Miolo Gianmaria, Maestro Roberta, de Paoli Paolo, Amoroso Antonio, Viel Alessand |
|
Young premenopausal women with breast cancer, especially estrogen receptor negative, are at significantly increased risk for subsequent ovarian cancer.
Discovery medicine 2016 10 22 (121): 209-213. Lehrer Steven, Rheinstein Peter H, Green Sheryl, Rosenzweig Kenneth |
- Page last reviewed:Jul 30, 2019
- Page last updated:Oct 31, 2019
- Content source: